Pure Global AI
NCT06377917Not yet recruiting

Investigating Micro-Manipulation Procedures for Assisted Hatching Timing

The IMPACT Trial: Investigating Micro-Manipulation Procedures for Assisted Hatching Timing
Reproductive Medicine Associates of New JerseyClinicalTrials.govother
Verified
Study focus
Disease/Condition
Infertility
Drug/Device/Intervention
Laser Assisted Hatching
Study type
Interventional
Intervention type
other
Sponsor & location
Primary sponsor
Reproductive Medicine Associates of New Jersey
Location
Marlton, United States of America
Timeline & enrollment
Phase
N/A
Start date
May 01, 2024
End date
May 01, 2026
Enrollment
75 participants
Primary outcome

Blastulation Rate

Summary

This study aims to assess the clinical significance of cleavage stage (Day 3) assisted
 hatching compared to assisted hatching at the blastocyst stage (Day 5,6,7) of embryo
 development at the time of trophectoderm (TE) biopsy for patients undergoing in vitro
 fertilization (IVF) and preimplantation genetic testing for aneuploidy (PGT-A) for treatment
 of their infertility.

ICD-10 classifications
Female infertilityMale infertilityFemale infertility, unspecifiedFemale infertility of other originFemale infertility of uterine origin
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT06377917
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT06377917 through Pure Global AI's free database. This phase not specified trial is sponsored by Reproductive Medicine Associates of New Jersey and is currently Not yet recruiting. The study focuses on Infertility. Target enrollment is 75 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.